Avastin (bevacizumab recalls
The FDA has published 2 recalls involving Avastin (bevacizumab since 2016. The latest was reported on 1 Jun 2016. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2016
Last 12 months0reported
Class I2100% of total
Ongoing0latest 1 Jun 2016
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 100%Class II 0 0%Class III 0 0%
Why avastin (bevacizumab is recalled
Companies
By year
All avastin (bevacizumab recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Avastin (Bevacizumab) 1.25 mg/ syringe recalled by Pacifico National | Pacifico National | Sterility | Nationwide |
| Drug | CLASS I | Avastin (Bevacizumab) 2 mg/ syringe recalled by Pacifico National | Pacifico National | Sterility | Nationwide |
Should you stop taking Avastin (bevacizumab?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.